THE non-selective muscarinic agonist oxotremorine induces atropine-sen
sitive neurite outgrowth in PC12 cells stably transfected with mi musc
arinic receptors. In contrast, AF102B, an M1-selective muscarinic agon
ist, mediated minimal neurite outgrowth in these cells. In the presenc
e of nerve growth factor (NGF) however, it induced atropine-sensitive
neurite outgrowth in almost half the cell population. AF102B mediated
phosphoinositide hydrolysis, but unlike carbachol, it did not stimulat
e cyclic AMP accumulation in these cells. These signals were not affec
ted by NGF, indicating that they were not directly responsible for the
cholinergic neurotrophic-like response. Our observations suggest that
AF102B may improve neuronal responsiveness to neurotrophic factors, a
nd thus may provide another beneficial aspect for treating Alzheimer's
disease.